The Arizona Bioscience Company of the Year is on a Mission to Cure the Uncurable

The Arizona Bioindustry Association ( AZBio ) today announced that Calimmune, Inc., acquired by CSL Limited in 2017, will be honored as the Arizona Bioscience Company of the Year by the state’s bioscience and business community at the 2018 AZBio Award on Oct. 3 at the Phoenix Convention Center.

On a mission to cure the incurable

When CSL Limited, the world’s 5th largest biotechnology company, acquired Arizona-based Calimmune in August 2017, the global biotechnology leader’s Chief Executive Officer, Paul Perreault, said, “Calimmune’s scientific accomplishments are impressive.”

Those accomplishments included accelerating the promise of gene therapy to liberate patients from chronic and currently incurable diseases.